232 related articles for article (PubMed ID: 18779315)
1. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes.
Nozell S; Laver T; Moseley D; Nowoslawski L; De Vos M; Atkinson GP; Harrison K; Nabors LB; Benveniste EN
Mol Cell Biol; 2008 Nov; 28(21):6632-45. PubMed ID: 18779315
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity.
Coles AH; Gannon H; Cerny A; Kurt-Jones E; Jones SN
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11423-8. PubMed ID: 20534538
[TBL] [Abstract][Full Text] [Related]
3. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
Byron SA; Min E; Thal TS; Hostetter G; Watanabe AT; Azorsa DO; Little TH; Tapia C; Kim S
PLoS One; 2012; 7(10):e46823. PubMed ID: 23056468
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.
Juvekar A; Manna S; Ramaswami S; Chang TP; Vu HY; Ghosh CC; Celiker MY; Vancurova I
Mol Cancer Res; 2011 Feb; 9(2):183-94. PubMed ID: 21224428
[TBL] [Abstract][Full Text] [Related]
6. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.
Batra S; Sahu RP; Kandala PK; Srivastava SK
Mol Cancer Ther; 2010 Jun; 9(6):1596-608. PubMed ID: 20484017
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Liu Y; Smith PW; Jones DR
Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Hou Y; Zhang Z; Xu Q; Wang H; Xu Y; Chen K
Oncogene; 2014 Apr; 33(15):1997-2003. PubMed ID: 23624912
[TBL] [Abstract][Full Text] [Related]
9. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.
Singh K; Sinha S; Malonia SK; Bist P; Tergaonkar V; Chattopadhyay S
J Biol Chem; 2009 Jan; 284(2):1267-78. PubMed ID: 18981184
[TBL] [Abstract][Full Text] [Related]
11. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.
Garkavtsev I; Kozin SV; Chernova O; Xu L; Winkler F; Brown E; Barnett GH; Jain RK
Nature; 2004 Mar; 428(6980):328-32. PubMed ID: 15029197
[TBL] [Abstract][Full Text] [Related]
12. Zac1 is a histone acetylation-regulated NF-κB suppressor that mediates histone deacetylase inhibitor-induced apoptosis.
Shu G; Tang Y; Zhou Y; Wang C; Song JG
Cell Death Differ; 2011 Dec; 18(12):1825-35. PubMed ID: 21546906
[TBL] [Abstract][Full Text] [Related]
13. The EZH1-SUZ12 complex positively regulates the transcription of NF-κB target genes through interaction with UXT.
Su SK; Li CY; Lei PJ; Wang X; Zhao QY; Cai Y; Wang Z; Li L; Wu M
J Cell Sci; 2016 Jun; 129(12):2343-53. PubMed ID: 27127229
[TBL] [Abstract][Full Text] [Related]
14. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.
Bhat KP; Pelloski CE; Zhang Y; Kim SH; deLaCruz C; Rehli M; Aldape KD
FEBS Lett; 2008 Sep; 582(21-22):3193-200. PubMed ID: 18708058
[TBL] [Abstract][Full Text] [Related]
15. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
16. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
[TBL] [Abstract][Full Text] [Related]
18. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.
Li S; Fan T; Liu H; Chen J; Qin C; Ren X
Mol Biol Rep; 2013 Oct; 40(10):5723-32. PubMed ID: 24057236
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.
Mathema VB; Koh YS
Tumour Biol; 2012 Feb; 33(1):1-7. PubMed ID: 21971889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
